RP Management, LLC
CIK 1507673 · View on SEC EDGAR ↗
- Portfolio value
- $138.8M
- Positions
- 4
- As of
- March 31, 2025 Data as of Q1 2025
#7,631 of 9,443 by 13F value · top 80.8%
Portfolio value QoQ: -39.0% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 3
- Effective number of positions
- 2.6
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q1 2025: 0.0% Est. buys $0 · sells $0
- New positions
- 0
- Increased
- 0
- Decreased
- 0
- Closed
- 0
On this page
Sector breakdown
Healthcare
100.0%
Full portfolio 4 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| BHVN Biohaven Ltd. Common Shares | $70,593,628 | 50.84% | 2,936,507 | $-76,143,627 | |||
| CYTK Cytokinetics, Incorporated - Common Stock | $39,401,954 | 28.38% | 980,392 | $-12,362,744 | |||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $28,846,155 | 20.78% | 3,846,154 | $-384,615 | |||
| VIRX | $74 | 0.00% | 3,700 | $-777 | |||
| No matches | |||||||
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| BHVN | Price move only | +0 | -$76.1M |
| CYTK | Price move only | +0 | -$12.4M |
| BCRX | Price move only | +0 | -$385K |
1 position hidden (data completeness check)